
Regeneron defeats Amgen in PCSK9 case; 2 cell therapy biotechs cut staff
Today, a brief rundown of news involving Amgen and Regeneron, as well as updates from Travere Therapeutics, Allogene and Kyverna Therapeutics that you may have missed. A federal jury has found Amgen liable for violating antitrust and tort laws by using “ …